COVID-19 Vaccine AstraZeneca (AZD1222): Clinical Overview on AZD1222 Anaphylaxis including Hypersensitivity

This document was acquired with a FOIA request submitted by the Informed Consent Action Network (ICAN) to the United Kingdom’s FDA equivalent – the Medicines and Healthcare Products Registry Agency (MHRA) – in April 2022. The request sought information relating to the MHRA’s authorization of the AstraZeneca, Janssen, Moderna, and Pfizer COVID-19 vaccines.